DBCO-PEG2-NHS ester is a bioorthogonal ADC linker combining DBCO reactive group with PEG2 spacer and NHS ester. It enables efficient site-specific payload conjugation via SPAAC click chemistry, enhancing antibody-drug conjugate stability and efficacy.
Structure of 2585653-12-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
DBCO-PEG2-NHS ester is a bifunctional reagent widely used for bioconjugation applications. Here are some key applications of DBCO-PEG2-NHS ester:
Protein Labeling: DBCO-PEG2-NHS ester facilitates the covalent attachment of proteins to a variety of surfaces or other biomolecules via click chemistry. By reacting with amine groups on proteins, researchers can achieve site-specific labeling without compromising protein function. This technique is essential for studying protein localization, interactions, and dynamics in complex biological systems.
Drug Delivery Systems: DBCO-PEG2-NHS ester is instrumental in the development of targeted drug delivery systems. By conjugating therapeutic agents to targeting ligands through PEG linkers, it ensures efficient and specific delivery to diseased tissues. This approach improves the therapeutic index of drugs and reduces off-target effects.
Biosensor Development: In biosensor technology, DBCO-PEG2-NHS ester is used to immobilize biomolecules on sensor surfaces. This enables the creation of highly sensitive and specific detection platforms for various analytes, including proteins, nucleic acids, and small molecules. Such biosensors are valuable in diagnostics, environmental monitoring, and food safety.
Surface Modification: DBCO-PEG2-NHS ester is utilized to modify the surfaces of nanoparticles, beads, and other materials to enhance their biocompatibility and functionality. By attaching bioligands or antifouling agents, these modified surfaces exhibit improved performance in biomedical applications such as imaging, biosensing, and therapeutics. This helps ensure that the materials interact with biological systems in a predictable and favorable manner.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01010 | DBCO-PEG4-amine | 1840886-10-3 | |
BADC-01017 | DBCO-PEG5-acid | 1870899-46-9 | |
BADC-01536 | DBCO-Peg4-VC-PAB-MMAE | 2129164-91-4 | |
BADC-01073 | DBCO-PEG5-NHS ester | 2144395-59-3 | |
BADC-01077 | DBCO-PEG4-DBCO | 2182601-68-7 | |
BADC-00863 | DBCO-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 | |
BADC-01089 | DBCO-PEG3 acetic-EVCit-PAB | 2253947-17-8 | |
BADC-00868 | DBCO-(PEG2-VC-PAB-MMAE)2 | 2259318-55-1 | |
BADC-00762 | DBCO-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-56-2 | |
BADC-00751 | DBCO-PEG4-MMAF | 2360411-65-8 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.